Pharma & Biotech
You will receive alerts when there are new announcements on Abimmune Biopharma
Only registered members can use this feature.
Abimmune Biopharma is a startup company that focuses on generating novel nanobody based drug candidates against a wide spectrum of high-value immunomodulatory and oncology targets related to T lymphocytes, solid tumors, and tumor stem cells.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.